Table 3.
Serum Osteopontin and Osteoprotegerin in relation to different parameters in RA (n = 20)
| (n = 20) | OPG | P | OPN | P | |
|---|---|---|---|---|---|
| Mean ± SD. | Mean ± SD. | ||||
| RF (< 15.9IU/ml) | |||||
| Negative | 2 | 60.50 ± 85.56 | 0.753 | 2.65 ± 0.35 | 0.753 |
| Positive | 18 | 153.15 ± 384.64 | 3.77 ± 4.43 | ||
| ACPA (< 20U/ml) | |||||
| Negative | 3 | 42.47 ± 68.09 | 0.341 | 3.58 ± 2.58 | 0.289 |
| Positive | 17 | 161.78 ± 394.67 | 4.13 ± 3.48 | ||
| Pain-VAS(0-10 mm) | |||||
| 5 - <7 | 4 | 14.58 ± 8.43 | 0.257 | 2.78 ± 2.39 | 0.344 |
| 7–10 | 16 | 176.21 ± 404.48 | 7.18 ± 7.92 | ||
| PGA(0-100 mm) | |||||
| 0–50 | 4 | 14.58 ± 8.43 | 0.257 | 2.78 ± 2.39 | 0.344 |
| > 50–100 | 16 | 176.21 ± 404.48 | 7.18 ± 7.92 | ||
p values for Mann Whitney test for comparing between the two groups
OPN: Osteopontin; OPG: Osteoprotegerin; RF: rheumatoid factor; ACPA: anti-citrullinated protein antibodies; VAS: Visual Analogue Scale; PGA: Patient global assessment